Aquestive Therapeutics (AQST) Inventory Average (2018 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Inventory Average of $7.1 million for Q1 2026, up 7.5% year-over-year from $6.6 million in Q1 2025, and up 1.3% quarter-over-quarter from $7.0 million in Q4 2025.
Aquestive Therapeutics (AQST) Inventory Average (2018 - 2026) Analysis & Trends
Aquestive Therapeutics' Inventory Average history runs 9 years deep, the most recent figure standing at $7.1 million for Q1 2026.
- In Q1 2026, Inventory Average rose 7.5% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (up 7.5% YoY), while the FY2025 annual figure was $6.1 million, down 4.68% from the prior year.
- Inventory Average for Q1 2026 stood at $7.1 million, up from $7.0 million in the prior quarter.
- The five-year high for Inventory Average was $8.0 million in Q3 2025, with the low at $4.3 million in Q1 2022.
- The 5-year median for Inventory Average is $6.6 million (2025), against an average of $6.6 million.
- The sharpest annual moves came in 2022 and 2025: Inventory Average surged 105.77% in 2022, then dropped 8.69% in 2025.
- Aquestive Therapeutics' Inventory Average stood at $6.3 million in 2022, then rose by 10.74% to $6.9 million in 2023, then fell by 5.65% to $6.5 million in 2024, then rose by 7.56% to $7.0 million in 2025, then climbed by 1.3% to $7.1 million in 2026.
- Business Quant data shows AQST's Inventory Average at $7.1 million in Q1 2026, $7.0 million in Q4 2025, and $8.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Aquestive Therapeutics | 551.85 Mn | 551.85 Mn | 9.80 Mn | 7.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.72 Mn |
| Mar 31, 2026 | 7.12 Mn |
| Dec 31, 2025 | 7.03 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 7.66 Mn |
| Mar 31, 2025 | 6.62 Mn |
| Dec 31, 2024 | 6.53 Mn |
| Sep 30, 2024 | 6.99 Mn |
| Jun 30, 2024 | 7.35 Mn |
| Mar 31, 2024 | 7.25 Mn |
| Dec 31, 2023 | 6.92 Mn |
| Sep 30, 2023 | 6.51 Mn |
| Jun 30, 2023 | 6.47 Mn |
| Mar 31, 2023 | 6.38 Mn |
| Dec 31, 2022 | 6.25 Mn |
| Sep 30, 2022 | 5.87 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | 4.33 Mn |
| Dec 31, 2021 | 3.45 Mn |
| Sep 30, 2021 | 2.85 Mn |